Hutchmed receives China NMPA conditional approval for Orpathys to treat gastric cancer patients with MET amplification: Hong Kong, Shanghai Saturday, July 4, 2026, 11:00 Hrs [IST] ...
AstraZeneca's selective MET inhibitor Orpathys has won conditional approval in China for a new indication in MET-amplified ...
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 02, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; ...
Getting a mortgage involves several steps, including prequalification and preapproval. One part of the process that’s perhaps not as well-known is conditional loan approval. Conditional loan approval ...
The high-grade glioma market is witnessing steady growth driven by the rising incidence of aggressive brain tumors, increasing awareness, and advancements ...
In this multicentre, prospective, observational, diagnostic accuracy study of children with suspected pulmonary embolism in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results